Skip to main content

Table 2 Summary results of bivariate model analysis and sub-group analysis

From: FDG-PET/CT versus bone marrow biopsy in bone marrow involvement in newly diagnosed paediatric lymphoma: a systematic review and meta-analysis

Summary results of bivariate model analysis
Bivariate Model Analysis
 Sen (95% CI) Spe (95% CI) PLR (95% CI) NLR (95% CI) DOR (95% CI) AUC (95% CI)
PET/CT
 0.97(0.93-0.99) 0.99(0.98-0.99) 79.9(42.7-149.6) 0.03(0.01-0.17) 2414.6(989.6-5891.4) 1.00(0.99-1.00)
BMB
 0.44(0.34-0.55) 1.00(0.92-1.00) 1277.1(4.8-337317.5) 0.56(0.46-0.68) 2274(9-596153) 0.71(0.67-0.75)
Subgroup Analyses
Subgroup Sen (95% CI) Spe (95% CI) PLR (95% CI) NLR (95% CI) DOR (95% CI) AUC (95% CI)
PET/CT
 HL 0.97(0.93-0.99) 0.99(0.97-0.99) 66.4(36.7-120.3) 0.03(0.01-0.07) 2532(865-7412) 1.00(0.99-1.00)
 NHL 0.94(0.85-0.97) 0.99(0.94-1.00) 68.9(15.7-302.9) 0.06(0.03-0.16) 1062(193-5853) 0.99(0.98-1.00)
BMB
 HL 0.32(0.18-0.50) 1.00(0.91-1.00) 231.8(2.9-18534.3) 0.68(0.53-0.87) 341(4-30241) 0.65(0.61-0.69)
 NHL 0.55(0.45-0.64) 0.99(0.95-1.00) 77.1(10.8-547.6) 0.46(0.37-0.56) 169(23-1250) 0.98(0.96-0.99)